Krsnaa Diagnostics Ltd.
Snapshot View

440.25 -0.70 ▼-0.2%

29 March 2023, 04:01:00 PM
Volume: 7,791

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.krsnaadiagnostics.com
Market Cap 1,399.55 Cr.
Enterprise Value(EV) 1,257.48 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 19.47 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 22.61 Trailing Twelve Months Ending 2022-12
Industry PE 46.41 Trailing Twelve Months Ending 2022-12
Book Value / Share 229.23 Trailing Twelve Months Ending 2022-12
Price to Book Value 1.92 Calculated using Price: 440.25
Dividend Yield 0.56 Period Ending 2022-03
No. of Shares Subscribed 3.14 Cr. 31,397,613 Shares
FaceValue 5
Company Profile
Krsnaa Diagnostics is one of the fastest-growing diagnostic chains in India. The company offers a wide range of diagnostic services such as imaging/radiology services (X-rays, MRI, etc.), routine clinical laboratory tests, pathology, and tele-radiology services to private and public hospitals, medical colleges, and community health centres.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-0.16%
1 Week
-2.33%
1 Month
+22.75%
3 Month
-3.70%
6 Month
-11.97%
1 Year
-10.04%
2 Year
5 Year
10 Year
1 years 2022-03
Return on Equity (%) 10.02
Return on Capital Employed (%) 14.47
Return on Assets (%) 7.81

Balance Sheet View Details >>

Particulars 2 years 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 684 706
Non Curr. Liab. 42 40
Curr. Liab. 149 176
Minority Int.
Equity & Liab. 875 922
Non Curr. Assets 541 591
Curr. Assets 334 332
Misc. Exp. not W/O
Total Assets 875 922

Profit Loss View Details >>

Particulars 2 years 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 455 462
Other Income 15 18
Total Income 470 480
Total Expenditure -324 -346
PBIDT 146 133
Interest -18 -7
Depreciation -41 -50
Taxation -18 -15
Exceptional Items
PAT 68 61
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 68 61
Adjusted EPS 22 19

Cash Flow View Details >>

Particulars 1 years 2022-03 Rs. Cr.
Cash Fr. Operatn. 128
Cash Fr. Inv. -241
Cash Fr. Finan. 176
Net Change 64
Cash & Cash Eqvt 88

Shareholding Pattern View Details >>

6 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 27.38 27.38 27.38 27.38 27.80 27.80
Public 72.62 72.62 72.62 72.62 72.20 72.20
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Sat, 25 Mar 2023
Board Meeting Outcome for Held On 25Th March 2023 Inter-Alia Approved The Formation Of Operations Committee (Non Statutory Committee).
This is to inform you that the Board of Directors of the Company at its meeting held today which commencedat 02:30 p.m. and concluded at 06:35 p.m. inter-alia approved the formation of Operations Committee(NonStatutoryCommittee).
Fri, 24 Mar 2023
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Tata Small Cap Fund & Tata India Equity Fund Multipartner SICAV
Mon, 20 Mar 2023
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 ("SEBI LODR") this is to inform you that the Company has been qualified as a L1 Bidder with regards to tender in consortium with Telecommunications Consultants India Ltd. with the Tender Estimated Size of INR 450 Crores by the National Health Mission Rajasthan for providing "Laboratory Services under Free Diagnostics Initiative on HUB and SPOKE Model under NHM" in the entire State of Rajasthan.

Technical Scans View Details >>

Tue, 28 Mar 2023
Opening at Low Opening at Low
Closing Below Previous Low Closing Below Previous Low
High Increase in 1 Month High Increase in 1 Month
Closing Near 100 SMA Closing Near 100 SMA
CCI Bearish CCI Bearish

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 237,702.12 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. 76,011.65 4,564.50 +0.8%
Divi's Laboratories Ltd. 74,827.63 2,818.70 +0.5%
Cipla Ltd. 71,662.87 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. 62,859.06 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. 52,616.42 1,554.65 +0.7%
Zydus Lifesciences Ltd. 49,628.37 490.30 +1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 56.44 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.86 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 31.22 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 27.16 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 82.20 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 63.32 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 24.08 490.30 +1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.30 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.45 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 6.01 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 3.16 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.19 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.25 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.88 490.30 +1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 0.04 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 490.30 +1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 490.30 +1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 490.30 +1.2%

FAQ's On Krsnaa Diagnostics Ltd.

What is Krsnaa Diagnostics share price?

Can I buy Krsnaa Diagnostics shares now?

What is the Dividend Yield of Krsnaa Diagnostics?

What is the Market Cap of Krsnaa Diagnostics?

What are the key metrics to analyse Krsnaa Diagnostics?

What is the 52 Week High and Low of Krsnaa Diagnostics?

What is the trend of Krsnaa Diagnostics share price?